journal
https://read.qxmd.com/read/38433973/virtual-physical-prehabilitation-in-lung-transplant-candidates-a-proof-of-concept-study
#21
JOURNAL ARTICLE
Nicholas Bourgeois, Larry C Lands, Karina Prévost, Charles Poirier, Tania Janaudis-Ferreira
This study aimed to preliminary test the effectiveness of 12-week virtual physical prehabilitation program followed by a maintenance phase. The main objective was to estimate the extent to which it affects exercise capacity, frailty, lower limb strength and health-related quality of life (HRQOL) in lung transplant candidates. The program offered supervised strengthening exercises, independent aerobic exercises and weekly phone calls (maintenance phase). Primary outcome was the six-minute walk distance (6MWD)...
2024: Transplant International
https://read.qxmd.com/read/38420269/corrigendum-real-world-treatment-patterns-of-antiviral-prophylaxis-for-cytomegalovirus-among-adult-kidney-transplant-recipients-a-linked-usrds-medicare-database-study
#22
Amit D Raval, Michael L Ganz, Kathy Fraeman, Andrea L Lorden, Shanmugapriya Saravanan, Yuexin Tang, Carlos A Q Santos
[This corrects the article DOI: 10.3389/ti.2022.10528.][This corrects the article DOI: 10.3389/ti.2023.12367.].
2024: Transplant International
https://read.qxmd.com/read/38420268/impact-of-transplantation-timing-on-renal-graft-survival-outcomes-and-perioperative-complications
#23
MULTICENTER STUDY
M Uhl, T Waeckel, E Seizilles De Mazancourt, F Taha, K Kaulanjan, A Goujon, A Beretta, J Papet, H Dupuis, A Panis, A Peyrottes, A Lemaire, C Larose, L Bettler, M Pues, C Joncour, G Stempfer, T Ghestem, P De Sousa
Nighttime organ transplantation aims to decrease cold ischemia duration, yet conflicting data exists on its impact on graft function and perioperative complications. This multicenter TRANSPLANT'AFUF study including 2,854 patients, transplanted between 1 January 2011, and 31 December 2022, investigated nighttime kidney transplantation's impact (8:00 p.m.-8:00 a.m.) versus daytime (8:00 a.m.-8:00 p.m.) on surgical complications and graft survival. Overall, 2043 patients (71.6%) underwent daytime graft, while 811 (28...
2024: Transplant International
https://read.qxmd.com/read/38414660/physical-exercise-after-solid-organ-transplantation-a-cautionary-tale
#24
REVIEW
Dimitri Stylemans, Marieke Vandecruys, Sofie Leunis, Sofie Engelborghs, Davide Gargioli, Diethard Monbaliu, Véronique Cornelissen, Amaryllis H Van Craenenbroeck, Stefan De Smet
An increasing body of randomized controlled trials suggests the safety of engaging in moderate to vigorous intensity exercise training following solid organ transplantation. Fueled by emerging sport events designed for transplant recipients and the ever-growing body of research highlighting the diverse health benefits of physical activity, transplant recipients are now increasingly participating in strenuous and occasionally competitive physical endeavors that largely surpass those evaluated in controlled research settings...
2024: Transplant International
https://read.qxmd.com/read/38389709/transplant-trial-watch
#25
EDITORIAL
Simon R Knight, John M O'Callaghan
No abstract text is available yet for this article.
2024: Transplant International
https://read.qxmd.com/read/38384325/pre-transplant-hyperparathyroidism-and-graft-or-patient-outcomes-after-kidney-transplantation
#26
JOURNAL ARTICLE
Fernanda Guedes Rodrigues, Willemijn Y Van Der Plas, Camilo German Sotomayor, Amarens Van Der Vaart, Daan Kremer, Robert A Pol, Schelto Kruijff, Ita Pfeferman Heilberg, Stephan J L Bakker, Martin H De Borst
The impact of pre-transplant parathyroid hormone (PTH) levels on early or long-term kidney function after kidney transplantation is subject of debate. We assessed whether severe hyperparathyroidism is associated with delayed graft function (DGF), death-censored graft failure (DCGF), or all-cause mortality. In this single-center cohort study, we studied the relationship between PTH and other parameters related to bone and mineral metabolism, including serum alkaline phosphatase (ALP) at time of transplantation with the subsequent risk of DGF, DCGF and all-cause mortality using multivariable logistic and Cox regression analyses...
2024: Transplant International
https://read.qxmd.com/read/38379606/aortobifemoral-bypass-in-kidney-transplant-candidates-a-ten-year-experience
#27
JOURNAL ARTICLE
Pascaline Bonnin, Salomé Kuntz, Sophie Caillard, Nabil Chakfé, Anne Lejay
In patients with severe aorto-iliac calcifications, vascular reconstructions can be performed in order to allow kidney transplantation. The aim of this study was to analyze the outcomes of kidney transplant candidates who underwent an aortobifemoral bypass (ABFB) for aorto-iliac calcifications. A retrospective study including all kidney transplant candidates who underwent an ABFB between 2012 and 2022 was performed. Primary outcome was 30-day morbidity-mortality after ABFB. Secondary outcome was accessibility to kidney transplant waiting list...
2024: Transplant International
https://read.qxmd.com/read/38371908/clinical-pig-heart-xenotransplantation-where-do-we-go-from-here
#28
JOURNAL ARTICLE
David K C Cooper, Emanuele Cozzi
No abstract text is available yet for this article.
2024: Transplant International
https://read.qxmd.com/read/38371907/higher-donor-age-and-severe-microvascular-inflammation-are-risk-factors-for-chronic-rejection-after-treatment-of-active-antibody-mediated-rejection
#29
JOURNAL ARTICLE
Taro Banno, Toshihito Hirai, Rikako Oki, Takafumi Yagisawa, Kohei Unagami, Taichi Kanzawa, Kazuya Omoto, Tomokazu Shimizu, Hideki Ishida, Toshio Takagi
Recent developments in intensive desensitization protocols have enabled kidney transplantation in human leukocyte antigen (HLA)-sensitized recipients. However, cases of active antibody-mediated rejection (AABMR), when they occur, are difficult to manage, graft failure being the worst-case scenario. We aimed to assess the impact of our desensitization and AABMR treatment regimen and identify risk factors for disease progression. Among 849 patients who underwent living-donor kidney transplantation between 2014 and 2021 at our institution, 59 were diagnosed with AABMR within 1 year after transplantation...
2024: Transplant International
https://read.qxmd.com/read/38362283/new-antibiotics-against-multidrug-resistant-gram-negative-bacteria-in-liver-transplantation-clinical-perspectives-toxicity-and-pk-pd-properties
#30
REVIEW
Andrea Lombardi, Laura Alagna, Emanuele Palomba, Giulia Viero, Anna Tonizzo, Davide Mangioni, Alessandra Bandera
Antimicrobial resistance is a growing global health problem, and it is especially relevant among liver transplant recipients where infections, particularly when caused by microorganisms with a difficult-to-treat profile, are a significant cause of morbidity and mortality. We provide here a complete dissection of the antibiotics active against multidrug-resistant Gram-negative bacteria approved over the last years, focusing on their activity spectrum, toxicity profile and PK/PD properties, including therapeutic drug monitoring, in the setting of liver transplantation...
2024: Transplant International
https://read.qxmd.com/read/38357217/late-onset-exudative-pleural-effusions-without-concomitant-airway-obstruction-or-lung-parenchymal-abnormalities-a-novel-presentation-of-chronic-lung-allograft-dysfunction
#31
JOURNAL ARTICLE
Devika Sindu, Sandhya Bansal, Bhuvin Buddhdev, Kendra McAnally, Hesham Mohamed, Rajat Walia, Thalachallour Mohanakumar, Sofya Tokman
Restrictive allograft syndrome (RAS) is an aggressive variant of CLAD characterized by progressive restrictive ventilatory decline and persistent pleuro-parenchymal changes that can be seen on chest CT. We identified four lung transplant recipients with a progressive restrictive ventilatory defect due to lymphocyte-predominant exudative pleural effusions, but no pleuro-parenchymal abnormalities typical of RAS. Using molecular analysis, we also found increased levels of previously described immune markers of RAS, including NFkB, 20S proteasome, lipocalin, TNFα, and TGFβ, within the circulating small extracellular vesicles of the remaining living lung transplant recipient...
2024: Transplant International
https://read.qxmd.com/read/38357216/peri-transplant-inflammation-and-long-term-diabetes-outcomes-were-not-impacted-by-either-etanercept-or-alpha-1-antitrypsin-treatment-in-islet-autotransplant-recipients
#32
JOURNAL ARTICLE
Tasneem R Abdel-Karim, James S Hodges, Kevan C Herold, Timothy L Pruett, Karthik V Ramanathan, Bernhard J Hering, Ty B Dunn, Varvara A Kirchner, Gregory J Beilman, Melena D Bellin
The instant blood-mediated inflammatory response (IBMIR) causes islet loss and compromises diabetes outcomes after total pancreatectomy with islet autotransplant (TPIAT). We previously reported a possible benefit of etanercept in maintaining insulin secretion 3 months post-TPIAT. Here, we report 2-year diabetes outcomes and peri-operative inflammatory profiles from a randomized trial of etanercept and alpha-1 antitrypsin (A1AT) in TPIAT. We randomized 43 TPIAT recipients to A1AT (90 mg/kg IV x6 doses, n = 13), etanercept (50 mg then 25 mg SQ x 5 doses, n = 14), or standard care ( n = 16)...
2024: Transplant International
https://read.qxmd.com/read/38344260/systems-connected-to-inequities-in-access-to-kidney-transplantation-and-the-value-of-intersectionality
#33
JOURNAL ARTICLE
Camilla W Nonterah
Patients from minoritized backgrounds based on race/ethnicity, gender, sexuality, and other social identities are more likely to experience inequities in access in kidney transplantation. Although these inequities have been reported over the decades, limited research focuses on the experiences of patients with intersecting minoritized social statuses and the mechanisms that contribute to their reduced access to transplantation. Intersectionality, a framework for understanding the ways in which multiple social identities represent interacting systems of oppression and privilege, offers a nuanced approach for understanding the experiences of patients diagnosed with end-stage organ disease with intersecting social identities...
2024: Transplant International
https://read.qxmd.com/read/38328617/covid-19-outcomes-in-lung-transplant-recipients-following-pre-exposure-prophylaxis-with-tixagevimab-cilgavimab-during-the-omicron-ba-5-surge-a-single-center-analysis
#34
JOURNAL ARTICLE
Saartje Demolder, Veronique Schaevers, Katrien Lagrou, Paul De Munter, Hanne Beeckmans, Geert M Verleden, Laurent Godinas, Lieven J Dupont, Pascal Van Bleyenbergh, Natalie Lorent, Robin Vos
Lung transplant (LTx) recipients are at high risk for COVID-19 related morbidity and mortality. Data regarding pre-exposure prophylaxis (PrEP) with tixagevimab-cilgavimab in this population are scarce. We therefore evaluated COVID-19 breakthrough infections and COVID-19 related complications after PrEP in a retrospective single-center study, including 264 LTx recipients who received PrEP between June 2022 and December 2022, when Omicron BA.5 was the dominant circulating SARS-CoV-2 variant. PrEP was indicated for fully vaccinated patients with poor seroconversion (anti-S <260 BAU/mL)...
2024: Transplant International
https://read.qxmd.com/read/38328616/cmv-infection-and-lymphopenia-warning-markers-of-pneumocystis-pneumonia-in-kidney-transplant-recipients
#35
JOURNAL ARTICLE
Isabelle Eberl, Christine Binquet, Adrien Guilloteau, Mathieu Legendre, Frederic Dalle, Lionel Piroth, Claire Tinel, Mathieu Blot
Pneumocystis pneumonia (PcP) remains life-threatening in kidney transplant recipients (KTR). Our study investigated risk factors one-year before PcP. We conducted a monocentric, case-control study including all KTR at the Dijon University Hospital (France) with a diagnosis of PcP between 2005 and 2022 (cases), and matched control KTR with no history of PcP (3 controls/case). Among all 1,135 KTR, 57 cases (5%) and 169 matched-controls were included. PcP was associated with 18% mortality. Compared to controls, cases were older, with a higher immunological risk, and CMV infection was more frequent in the year preceding the occurrence of PcP (23% vs...
2024: Transplant International
https://read.qxmd.com/read/38323071/unveiling-the-incidence-and-graft-survival-rate-in-kidney-transplant-recipients-with-de-novo-thrombotic-microangiopathy-a-systematic-review-and-meta-analysis
#36
JOURNAL ARTICLE
Chien-Ya Hsiung, Hsin-Yu Chen, Shih-Han Wang, Ching-Ying Huang
De novo thrombotic microangiopathy (TMA) is a rare and challenging condition in kidney transplant recipients, with limited research on its incidence and impact on graft survival. This study conducted a systematic review and meta-analysis of 28 cohorts/single-arm studies and 46 case series/reports from database inception to June 2022. In meta-analysis, among 14,410 kidney allograft recipients, de novo TMA occurred in 3.20% [95% confidence interval (CI): 1.93-4.77], with systemic and renal-limited TMA rates of 1...
2024: Transplant International
https://read.qxmd.com/read/38323070/predicting-tacrolimus-concentrations-in-the-skin-of-adult-kidney-transplant-recipients-a-feasibility-study
#37
JOURNAL ARTICLE
Felicity Sartain, Andrea K Viecelli, Margaret Veitch, Michael E Franklin, Brian W Dymock, James W Wells, Scott B Campbell
Solid organ transplant recipients are at an increased risk of developing skin cancers due to chronic immunosuppression, particularly with calcineurin inhibitors. Tacrolimus is the most prescribed calcineurin inhibitor in this patient cohort, and understanding tacrolimus concentrations in the skin will facilitate the development of anti-cancer preventive and therapeutic strategies. Here, we show that in mice, tacrolimus blood levels peaked rapidly ∼1 h post last oral dose while skin levels rose more slowly and remained high for at least 6 h...
2024: Transplant International
https://read.qxmd.com/read/38317691/transplant-trial-watch
#38
EDITORIAL
John M O'Callaghan, Simon R Knight
No abstract text is available yet for this article.
2024: Transplant International
https://read.qxmd.com/read/38317690/the-advent-of-semi-elective-lung-transplantation-prolonged-static-cold-storage-at-10%C3%A2-c
#39
REVIEW
K Hoetzenecker, A Benazzo, S Schwarz, S Keshavjee, M Cypel
Since the early days of clinical lung transplantation the preservation of donor organs has become a fairly standardized procedure and most centers do follow similar processes. This includes the use of low-potassium high dextran flush solutions and static cold storage (SCS) in a cooler filled with ice. Depending on the length of SCS, organs usually arrive at the recipient hospital at a temperature of 0°C-4°C. The question of the optimal storage temperature for donor lung preservation has been revisited as data from large animal experiments demonstrated that organs stored at 10°C experience less mitochondrial damage...
2024: Transplant International
https://read.qxmd.com/read/38314399/a-novel-case-of-cmv-resistance-to-valganciclovir-and-maribavir-in-a-renal-transplant-patient
#40
JOURNAL ARTICLE
Helen Pearce, Emma K Montgomery, Neil Sheerin, Helena Ellam
No abstract text is available yet for this article.
2024: Transplant International
journal
journal
20283
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.